Theravance Biopharma Inc (TBPH)

May 05, 2026

MSN Money - MSN

May 05, 2026

May 04, 2026

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 04, 2026

May 04, 2026

Theravance's Q4 earnings and revenues miss estimates - MSN

May 04, 2026

May 03, 2026

Theravance stock declines around 17% in three months: Here's why - MSN

May 03, 2026

Apr 30, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire

Apr 30, 2026

Apr 28, 2026

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent

Apr 28, 2026

Apr 28, 2026

Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan

Apr 28, 2026

Apr 28, 2026

A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet

Apr 28, 2026

Apr 27, 2026

Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN

Apr 27, 2026

Apr 26, 2026

Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN

Apr 26, 2026

Apr 25, 2026

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 25, 2026

Apr 24, 2026

Laughing Water Capital Adds Theravance Biopharma to Portfolio in Q1 2026 - HarianBasis.co

Apr 24, 2026

Apr 24, 2026

Laughing Water Capital’s New Position: Theravance Biopharma, Inc. (TBPH) - Insider Monkey

Apr 24, 2026

Apr 24, 2026

Laughing Water Capital’s New Position: Theravance Biopharma (TBPH) - Yahoo Finance

Apr 24, 2026

Apr 23, 2026

Theravance and Mylan settle patent dispute with Eugia Pharma - MSN

Apr 23, 2026

Apr 23, 2026

How (TBPH) Movements Inform Risk Allocation Models - Stock Traders Daily

Apr 23, 2026

Apr 23, 2026

Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Apr 23, 2026

Apr 22, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 22, 2026

Apr 21, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Reach Out - ACCESS Newswire

Apr 21, 2026

Apr 21, 2026

Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH) - Seeking Alpha

Apr 21, 2026

Apr 20, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Theravance Biopharma, Inc. (TBPH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 20, 2026

Apr 20, 2026

Theravance Biopharma (TBPH) Stock: What Investors Should Know (-0.75%) 2026-04-20Buy Signals - Xã Thanh Hà

Apr 20, 2026

Apr 19, 2026

B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 - Insider Monkey

Apr 19, 2026

Apr 19, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 19, 2026

Apr 19, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewir - The National Law Review

Apr 19, 2026

Apr 17, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 17, 2026

Apr 17, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside - DirectorsTalk Interviews

Apr 17, 2026

Apr 16, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Investors to Connect - ACCESS Newswire

Apr 16, 2026

Apr 16, 2026

Theravance Stock Declines Around 17% in Three Months: Here's Why - Yahoo Finance

Apr 16, 2026

Apr 16, 2026

TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP - GlobeNewswire

Apr 16, 2026